Page 33 - Current Evidence News Today

COVID-19, a disease caused by the novel coronavirus SARS-CoV-2, has been drastically affecting the daily lives of millions of people. COVID-19 is described as a multiorgan disease that affects not only the respiratory tract of infected individuals, but it has considerable effects on the musculoskeletal system, causing excessive fatigue, myalgia, arthralgia, muscle weakness and skeletal muscle damage. These symptoms can persist for months, decreasing the quality of life of numerous individuals. C...

Liquid biopsy is becoming more and more promising for solid tumour research, detection and surveillance. Here, Lab News asks Dr Han Wei what liquid...

An unsystematic survey of the effect of SARS-COV-2, the virus, on sleeping individuals; and the effect of COVID-19, the disease, on populations.

Tories accused of ‘toning down’ report backing drug consumption rooms A Government-funded research paper was highly ­modified after major support in Scotland emerged for life-saving facilities. Changes were applied after the Home Office was criticised (Image: Supplied) Join thousands of others in getting the stories that matter to you sent straight to your inbox.Invalid EmailSomething went wrong, please try again later. Subscribe When you subscribe we will use the information you p...

Repurposing Drugs for COVID-19 Drug repurposing The term ‘drug repurposing’ refers to the process by which new therapeutic uses for existing drugs are identified. Also referred to as ‘repositioning’ or ‘re-profiling’, the approach is generally considered to be both economical and efficient and as very few drugs possess absolute selectivity of action, many have the potential to work against other or new diseases. Image Credit: eamesBot / Shutterstock.com Repurposing drugs and COVID-1...